IRCT2015120525372N1已完成未知
Effect of allopurinol in preventing contrast induced nephropathy among patients undergoing elective PCI
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •All patients undergoing elective PCI
- •Exclusion criteria: Patients who are candidates for CABG or primary PCI; Patients with gout or prior use of allopurinol; Serum creatinin >3mg/dL or eGFR<60ml/min; Advanced hepatic failure; Patients who are using azathioprine, 6MP, or warfarin; Patients who have not filled/signed consent form, or the ones who had shown adverse reaction to the drug in prior use
排除标准
- 未提供
研究者
相似试验
已完成
3 期
The effect of Allopurinol in prevention of contrast induced nephropathy in patients undergoing angioplastyephropathy.Disorder of kidney and ureter, unspecified28.9IRCT20190406043182N1Tabriz University of Medical Sciences100
进行中（未招募）
1 期
Estudio para valorar el efecto sobre las plaquetas del tratamiento con Alopurinol en pacientes diabéticosEUCTR2011-000619-16-ESFundación Investigación Biomedica. Hospital Clinico San Carlos
进行中（未招募）
1 期
Comparison of 2 contrast agents in preventing acute renal failure after angiographyEUCTR2005-001986-32-GBHS Tayside
尚未招募
3 期
Evaluation of the effect of Allopurinol on the frequency of ventricular and supraventricular arrhythmiasCondition 1: Ventricular arrhythmias. Condition 2: Supraventricular arrhythmia.Re-entry ventricular arrhythmiaI47.0I47.1Supraventricular tachycardiaIRCT20120520009801N12Mashhad University of Medical Sciences134
Unknown
2 期
Effect of Allopurinol or Febuxostat to Prevent Contrast Induced Acute Kidney Injury (CI-AKI)Contrast-induced Acute Kidney InjuryContrast-induced NephropathyNCT03767322Instituto Nacional de Cardiologia Ignacio Chavez558